ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Interim Money Bill Passes; NCI Can Start Awarding Grants, Contract With 1980 funds, Until Nov. 20

October 26, 1979

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

ACS Encourages Research Proposals Psychosocial Aspects Of Cancer

March 26, 1982

Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds

March 28, 2003

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003